glycine has been researched along with Multiple Sclerosis, Chronic Progressive in 1 studies
Multiple Sclerosis, Chronic Progressive: A form of multiple sclerosis characterized by a progressive deterioration in neurologic function which is in contrast to the more typical relapsing remitting form. If the clinical course is free of distinct remissions, it is referred to as primary progressive multiple sclerosis. When the progressive decline is punctuated by acute exacerbations, it is referred to as progressive relapsing multiple sclerosis. The term secondary progressive multiple sclerosis is used when relapsing remitting multiple sclerosis evolves into the chronic progressive form. (From Ann Neurol 1994;36 Suppl:S73-S79; Adams et al., Principles of Neurology, 6th ed, pp903-914)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acute secondary progressive multiple sclerosis (SPMS) is characterized by escalating neurological disability, with limited disease-modifying therapeutic options." | 5.72 | Guanidinoacetate-creatine in secondary progressive multiple sclerosis: a case report. ( Jezdimirovic, T; Ostojic, J; Ostojic, SM; Stajer, V; Zanini, D, 2022) |
| "Acute secondary progressive multiple sclerosis (SPMS) is characterized by escalating neurological disability, with limited disease-modifying therapeutic options." | 1.72 | Guanidinoacetate-creatine in secondary progressive multiple sclerosis: a case report. ( Jezdimirovic, T; Ostojic, J; Ostojic, SM; Stajer, V; Zanini, D, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ostojic, SM | 1 |
| Ostojic, J | 1 |
| Zanini, D | 1 |
| Jezdimirovic, T | 1 |
| Stajer, V | 1 |
1 other study available for glycine and Multiple Sclerosis, Chronic Progressive
| Article | Year |
|---|---|
Guanidinoacetate-creatine in secondary progressive multiple sclerosis: a case report.
Topics: Creatine; Female; Glycine; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Multiple Sclerosis; | 2022 |